1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Tiziano Frateschi
Tiziano Frateschi
Articles (2425)  | Author's Website |

5 Peter Lynch Stocks With a Margin of Safety

Bio-Rad Labs tops the list

April 06, 2020 | About:

According to the GuruFocus All-in-One Screener, a Premium feature, as of March 30, the following companies are trading below their Peter Lynch fair value with wide margins of safety and have had positive performances over the past 12 months.

Mastech Digital

Mastech Digital Inc. (MHH) was trading around $9.75 per share as of April 6. The Peter Lynch fair value is $20.62, which suggests it is undervalued with a 53% margin of safety. The stock registered a 52-week increase of 58.79%.

8c4774a856299011c40260e0a6b131ba.png

The provider of IT services has a market cap of $109 million and an enterprise value of $136 million.

The stock is trading with a price-earnings ratio of 9.85. The share price is currently 45.35% below its 52-week high and 116.19% above its 52-week low. The price-book ratio is 2.32.

Jim Simons (Trades, Portfolio)’ Renaissance Technologies is the company's largest guru shareholder with 0.75% of outstanding shares.

Kemet

Kemet Corp. (KEM) was trading around $24.40 per share as of Monday. The Peter Lynch fair value is $57, which suggests it is undervalued with a 57% margin of safety. Over the past 52 weeks, the stock has returned 36.38%.

97fb21a502bf137b48b4637cd15ee2ae.png

The manufacturer and seller of passive electronic components has a market cap of $1.42 billion and an enterprise value of $1.53 billion.

The stock is trading with a price-earnings ratio of 10.71, which is higher than 67% of companies in the hardware industry. The share price is currently 11.55% below its 52-week high and 53.88% above its 52-week low.

The company's largest guru shareholder is Simons’ firm with 1.46% of outstanding shares, followed by Chuck Royce (Trades, Portfolio) with 1.30% and Scott Black (Trades, Portfolio) with 0.13%.

The Goldfield

The Goldfield Corp. (GV) was trading around $2.79 per share as of April 6. The Peter Lynch fair value gives the stock a fair price of $4.37, which suggests it is undervalued with a 36% margin of safety. Over the past 12 months, the stock has increased 19.88%.

6d6fb8278b48d9e3d6def5d186d1c98a.png

The constructor if infrastructures has a market cap of $68.4 million and an enterprise value of $79.28 million.

The stock is trading with a price-earnings ratio of 10.33, which is lower than 53% of companies in the construction industry. The share price is currently 29.19% below its 52-week high and 41.62% above its 52-week low.

Simons’ Renaissance Technologies is the company's largest guru shareholder with 7.89% of outstanding shares.

Centene

Centene Corp. (CNC) was trading around $54.60 per share as of Monday. The Peter Lynch fair value is $67.89, which suggests the company is undervalued with a 20% margin of safety. Over the past 52 weeks, the stock has increased 2.30%.

a4271cca9dff74948dbde85abef822f3.png

The healthcare plans provider has a market cap of $32.04 billion and an enterprise value of $32.89 billion.

The stock is trading with a price-earnings ratio of 17.39, which is lower than 82% of companies in the healthcare plans industry. The share price is currently 20.45% below its 52-week high and 31.19% above its 52-week low.

The company's largest guru shareholders are Andreas Halvorsen (Trades, Portfolio)’s Viking Global Investors with 1.86% of outstanding shares, Vanguard Health Care Fund (Trades, Portfolio) with 1.47% and Lee Ainslie (Trades, Portfolio)’s Maverick Capital with 0.54%.

Bio-Rad Laboratories

Bio-Rad Laboratories Inc. (BIO) was trading around $366 per share as of April 6. The Peter Lynch fair value gives the stock a fair price of $1,455, which suggests it is undervalued with a 75% margin of safety. Over the past 12 months, the stock price has increased 19.58%.

e1cb1627ee3107b8411901757c6066fc.png

The manufacturer and seller of medical systems has a market cap of $10.94 billion and an enterprise value of $10.48 billion.

The stock is trading with a price-earnings ratio of 6.28, which is higher than 97% of companies in the medical devices and instruments industry. The share price is currently 11.44% below its 52-week high and 36% above its 52-week low.

John Rogers (Trades, Portfolio) is the company's largest guru shareholder with 0.76% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.75% and NWQ Managers (Trades, Portfolio) with 0.43%.

Disclosure: I do not own any stocks mentioned in this article.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

About the author:

Tiziano Frateschi
You can read about me on www.theextraincome.info, which gives suggestions on position trading.

Visit Tiziano Frateschi's Website


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Tiziano Frateschi


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)